These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 9821299

  • 1. Antitumor activity of paclitaxel and epirubicin in human breast carcinoma, R-27.
    Asanuma F, Yamada Y, Kawamura E, Lee K, Kobayashi H, Yamada T, Suzuki T, Kubota T.
    Folia Microbiol (Praha); 1998; 43(5):473-4. PubMed ID: 9821299
    [Abstract] [Full Text] [Related]

  • 2. [Role of taxanes in treatment of breast cancer].
    Gorbunova VA, Besova NS.
    Vopr Onkol; 2004; 50(4):492-500. PubMed ID: 15605777
    [No Abstract] [Full Text] [Related]

  • 3. Docetaxel and epirubicin plus G-CSF as mobilizing treatment to support high-dose chemotherapy in breast cancer.
    De Rosa L, Lalle M, Perillo A, Pierelli L, Salerno MG, Cortesi E, Martelli O, Pandolfi A, Amodeo R, Marzetti L, Mancuso S, Scambia G.
    Anticancer Res; 2001; 21(2B):1367-70. PubMed ID: 11396215
    [Abstract] [Full Text] [Related]

  • 4. Schedule-dependent and -independent antitumor activity of paclitaxel-based combination chemotherapy against M-109 murine lung carcinoma in vivo.
    Fujimoto S, Chikazawa H.
    Jpn J Cancer Res; 1998 Dec; 89(12):1343-51. PubMed ID: 10081496
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
    Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, Taguchi T, Tamaki Y, Noguchi S.
    Clin Cancer Res; 2009 Jun 15; 15(12):4234-41. PubMed ID: 19509181
    [Abstract] [Full Text] [Related]

  • 7. Paclitaxel and epirubicin as first-line therapy for patients with metastatic breast cancer.
    Lück HJ, Du Bois A, Thomssen C, Lisboa B, Untch M, Köhler G, Hecker D.
    Oncology (Williston Park); 1997 Apr 15; 11(4 Suppl 3):34-7. PubMed ID: 9144689
    [Abstract] [Full Text] [Related]

  • 8. Greater antitumor efficacy of paclitaxel administered before epirubicin in a mouse mammary carcinoma.
    Cividalli A, Cruciani G, Livdi E, Cordelli E, Eletti B, Tirindelli Danesi D.
    J Cancer Res Clin Oncol; 1998 Apr 15; 124(5):236-44. PubMed ID: 9645453
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Paclitaxel, epirubicin and cyclophosphamide combination in first-line treatment of metastatic breast cancer: a dose escalation study.
    Bonneterre J, Tubiana-Hulin M, Catimel G.
    Oncology; 2004 Apr 15; 66(3):185-91. PubMed ID: 15218308
    [Abstract] [Full Text] [Related]

  • 11. [Antitumor activity of UFT and docetaxel on human breast carcinoma xenografts].
    Yamada T, Yamada Y, Asanuma F, Kawamura E, Suzuki T.
    Gan To Kagaku Ryoho; 2000 Oct 15; 27(11):1725-30. PubMed ID: 11057324
    [Abstract] [Full Text] [Related]

  • 12. Metastatic breast cancer: experience with the combination paclitaxel plus epirubicin.
    Lück HJ, Thomssen C, Du Bois A, Untch M, Lisboa B, Köhler G, Diergarten K.
    Oncology (Williston Park); 1998 Jan 15; 12(1 Suppl 1):36-9. PubMed ID: 9516602
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of paclitaxel or doxorubicin used as single agents in advanced breast cancer: a literature survey.
    Paridaens R.
    Semin Oncol; 1998 Oct 15; 25(5 Suppl 12):3-6. PubMed ID: 9865704
    [Abstract] [Full Text] [Related]

  • 14. Paclitaxel plus epirubicin in advanced breast cancer.
    Conte PF, Gennari A, Salvadori B, Pazzagli C, Bengala C.
    Oncology (Williston Park); 1998 Jan 15; 12(1 Suppl 1):40-4. PubMed ID: 9516603
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro search for synergy and antagonism: evaluation of docetaxel combinations in breast cancer cell lines.
    Budman DR, Calabro A.
    Breast Cancer Res Treat; 2002 Jul 15; 74(1):41-6. PubMed ID: 12150451
    [Abstract] [Full Text] [Related]

  • 18. Drug resistance gene expression and chemotherapy sensitivity detection in Chinese women with different molecular subtypes of breast cancer.
    Zhao J, Zhang H, Lei T, Liu J, Zhang S, Wu N, Sun B, Wang M.
    Cancer Biol Med; 2020 Nov 15; 17(4):1014-1025. PubMed ID: 33299650
    [Abstract] [Full Text] [Related]

  • 19. [A case of giant advanced ulcerative breast cancer managed with epirubicin and cyclophosphamide followed by weekly paclitaxel].
    Moriya T, Fukatsu K, Ueda S, Iwaya K, Osaki A, Yamamoto J.
    Gan To Kagaku Ryoho; 2010 May 15; 37(5):907-10. PubMed ID: 20495326
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.